Key result
This review discusses strategies for the periprocedural management of anticoagulation, including bridging therapy, in patients taking vitamin K antagonists or direct oral anticoagulants who require non-cardiac surgery.
Why the study?
Periprocedural anticoagulation management in non-cardiac surgery is an increasing clinical challenge, balancing thromboembolic and hemorrhagic risks alongside debates surrounding bridging therapy.
This review provides an overview of periprocedural anticoagulation management strategies for patients undergoing non-cardiac surgery, emphasizing the balance between bleeding and thromboembolic risks.
No takes yet. Share an insight, caveat, or question.
Should not yet change periprocedural anticoagulation practices; leaves open optimal bridging strategies pending randomized trials.
Carlo Rostagno (2022) conducted a review in Patients on anticoagulant therapy requiring non-cardiac surgery. Periprocedural management of anticoagulation was evaluated. This review discusses strategies for the periprocedural management of anticoagulation, including bridging therapy, in patients taking vitamin K antagonists or direct oral anticoagulants who require non-cardiac surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: